BCL2L1 and ovarian cancer: Interestingly, ovarian cancers with relatively high Bcl-xL levels are less responsive to taxane-based therapy, and ovarian cancer cell lines with higher Bcl-xL/Mcl-1 ratios showed higher Bliss sum values when treated with Navitoclax and taxol [45].